176 related articles for article (PubMed ID: 30720161)
1. miR-490-3p modulates the progression of prostate cancer through regulating histone deacetylase 2.
Fan H; Zhang YS
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):539-546. PubMed ID: 30720161
[TBL] [Abstract][Full Text] [Related]
2. MiR-506-3p acts as a novel tumor suppressor in prostate cancer through targeting GALNT4.
Hu CY; You P; Zhang J; Zhang H; Jiang N
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5133-5138. PubMed ID: 31298366
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding TUG1 accelerates prostate cancer progression through regulating miR-128-3p/YES1 axis.
Hao SD; Ma JX; Liu Y; Liu PJ; Qin Y
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):619-632. PubMed ID: 32016963
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-92a-3p regulates the expression of cartilage-specific genes by directly targeting histone deacetylase 2 in chondrogenesis and degradation.
Mao G; Zhang Z; Huang Z; Chen W; Huang G; Meng F; Zhang Z; Kang Y
Osteoarthritis Cartilage; 2017 Apr; 25(4):521-532. PubMed ID: 27884646
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-455-3p functions as a tumor suppressor by targeting HDAC2 to regulate cell cycle in hepatocellular carcinoma.
Ma F; Huang J; Li W; Li P; Liu M; Xue H
Environ Toxicol; 2022 Jul; 37(7):1675-1685. PubMed ID: 35286011
[TBL] [Abstract][Full Text] [Related]
6. The miR-455-3p/HDAC2 axis plays a pivotal role in the progression and reversal of liver fibrosis and is regulated by epigenetics.
You H; Wang L; Bu F; Meng H; Pan X; Li J; Zhang Y; Wang A; Yin N; Huang C; Li J
FASEB J; 2021 Jul; 35(7):e21700. PubMed ID: 34105828
[TBL] [Abstract][Full Text] [Related]
7. lncRNA-SNHG15 accelerates the development of hepatocellular carcinoma by targeting miR-490-3p/ histone deacetylase 2 axis.
Dai W; Dai JL; Tang MH; Ye MS; Fang S
World J Gastroenterol; 2019 Oct; 25(38):5789-5799. PubMed ID: 31636472
[TBL] [Abstract][Full Text] [Related]
8. MiR-363-3p promotes prostate cancer tumor progression by targeting Dickkopf 3.
Xu LZ; Ning JZ; Ruan Y; Cheng F
J Clin Lab Anal; 2022 Apr; 36(4):e24360. PubMed ID: 35303365
[TBL] [Abstract][Full Text] [Related]
9. The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1.
Li SM; Wu HL; Yu X; Tang K; Wang SG; Ye ZQ; Hu J
J Exp Clin Cancer Res; 2018 Sep; 37(1):219. PubMed ID: 30185212
[TBL] [Abstract][Full Text] [Related]
10. TGF-β1-regulated miR-3691-3p targets
Hu YM; Lou XL; Liu BZ; Sun L; Wan S; Wu L; Zhao X; Zhou Q; Sun MM; Tao K; Zhang YS; Wang SL
Asian J Androl; 2021; 23(2):188-196. PubMed ID: 33159025
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer.
Shen PF; Chen XQ; Liao YC; Chen N; Zhou Q; Wei Q; Li X; Wang J; Zeng H
Prostate; 2014 May; 74(7):756-67. PubMed ID: 24644030
[TBL] [Abstract][Full Text] [Related]
12. miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells.
Liu R; Liu C; Zhang D; Liu B; Chen X; Rycaj K; Jeter C; Calhoun-Davis T; Li Y; Yang T; Wang J; Tang DG
Oncotarget; 2016 Aug; 7(35):56628-56642. PubMed ID: 27447749
[TBL] [Abstract][Full Text] [Related]
13. MiR-455-3p activates Nrf2/ARE signaling via HDAC2 and protects osteoblasts from oxidative stress.
Zhang S; Wu W; Jiao G; Li C; Liu H
Int J Biol Macromol; 2018 Feb; 107(Pt B):2094-2101. PubMed ID: 29042277
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of miR-489-3p Attenuates Cerebral Ischemia/Reperfusion Injury by Targeting Histone Deacetylase 2 (HDAC2).
Jia T; Wang M; Yan W; Wu W; Shen R
Neuroscience; 2022 Feb; 484():16-25. PubMed ID: 34914969
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer.
Huang S; Wa Q; Pan J; Peng X; Ren D; Huang Y; Chen X; Tang Y
J Exp Clin Cancer Res; 2017 Dec; 36(1):173. PubMed ID: 29202848
[TBL] [Abstract][Full Text] [Related]
16. METTL3-mediated m6A modification of pri-miR-148a-3p affects prostate cancer progression by regulating TXNIP.
Li G; Liu J; Wang Y; Liu H; Fu J; Zhao Y; Huang Y
Environ Toxicol; 2023 Oct; 38(10):2377-2390. PubMed ID: 37449729
[TBL] [Abstract][Full Text] [Related]
17. miR-15a-3p Suppresses Prostate Cancer Cell Proliferation and Invasion by Targeting SLC39A7 Via Downregulating Wnt/β-Catenin Signaling Pathway.
Cui Y; Yang Y; Ren L; Yang J; Wang B; Xing T; Chen H; Chen M
Cancer Biother Radiopharm; 2019 Sep; 34(7):472-479. PubMed ID: 31135177
[No Abstract] [Full Text] [Related]
18. miR-199a-3p inhibits aurora kinase A and attenuates prostate cancer growth: new avenue for prostate cancer treatment.
Qu Y; Huang X; Li Z; Liu J; Wu J; Chen D; Zhao F; Mu D
Am J Pathol; 2014 May; 184(5):1541-9. PubMed ID: 24631181
[TBL] [Abstract][Full Text] [Related]
19. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.
Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M
J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-455-3p modulates cartilage development and degeneration through modification of histone H3 acetylation.
Chen W; Chen L; Zhang Z; Meng F; Huang G; Sheng P; Zhang Z; Liao W
Biochim Biophys Acta; 2016 Dec; 1863(12):2881-2891. PubMed ID: 27638301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]